WASHINGTON (September 13, 2013)—U.S. House lawmakers have introduced legislation that would mean more federal oversight for large specialty pharmacies such as the one that triggered a deadly meningitis outbreak last year.
The bill introduced by Republicans and Democrats would subject large compounding operations to regular inspections, fees and other requirements from the Food and Drug Administration.
State pharmacy boards now oversee pharmacies, including compounders that mix customized medicines.
The effort comes almost a year after the emergence of an outbreak linked to contaminated drugs from a Massachusetts pharmacy, which killed at least 64 people and sickened 750 more.
The bill's co-author, U.S. Rep. Morgan Griffith, R-Va., said the legislation would prevent similar outbreaks and ensure the "quality and safety of all compounded drugs in the country."
The Senate introduced similar legislation in May.